Literature DB >> 8408866

Antimicrobial susceptibility of bifidobacteria.

K S Lim1, C S Huh, Y J Baek.   

Abstract

The antimicrobial susceptibility of 37 strains of bifidobacteria to 18 antimicrobial agents was determined by a macrodilution broth method. Most of the strains used were isolated from commercial yogurts and starters. Tested organisms were usually sensitive to Gram-positive spectrum antibiotics (bacitracin, erythromycin, lincomycin, and vancomycin), and most of the organisms were inhibited by a concentration < 1.56 micrograms/ml. Erythromycin was the most active agent; all strains were inhibited by < .19 microgram/ml. beta-Lactam antibiotics (penicillin G, ampicillin, methicillin, and cephalothin), showing a wide range of minimum inhibitory concentration, were less effective than Gram-positive spectrum antibiotics. Most strains were somewhat resistant to cephalothin, exhibiting inhibition at concentrations of 6.25 to 25.0 micrograms/ml. Test organisms were most resistant to kanamycin, neomycin, paromomycin sulfate, nalidixic acid, and polymyxin B sulfate; inhibition occurred only at > or = 50 micrograms/ml, and strains were somewhat less resistant to gentamicin and streptomycin. Susceptibility to nitrofurantoin and tetracycline was variable; minimum inhibitory concentrations ranged from 1.56 to 50.0 and .39 to 50.0 micrograms/ml, respectively, but chloramphenicol had a narrow range from 1.56 to 6.25 micrograms/ml.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8408866     DOI: 10.3168/jds.S0022-0302(93)77553-0

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  10 in total

1.  Evaluation of new broth media for microdilution antibiotic susceptibility testing of Lactobacilli, Pediococci, Lactococci, and Bifidobacteria.

Authors:  Ingo Klare; Carola Konstabel; Sibylle Müller-Bertling; Rolf Reissbrodt; Geert Huys; Marc Vancanneyt; Jean Swings; Herman Goossens; Wolfgang Witte
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

2.  Resistance of Bifidobacteria and Lactobacilli to tobramycin.

Authors:  W Heine; C Mohr; S Ullrich; C Plath; M Uhlemann
Journal:  Eur J Pediatr       Date:  1996-05       Impact factor: 3.183

3.  Macrolide resistance mediated by a Bifidobacterium breve membrane protein.

Authors:  Abelardo Margolles; José Antonio Moreno; Douwe van Sinderen; Clara G de Los Reyes-Gavilán
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.

Authors:  E Kheadr; N Dabour; C Le Lay; C Lacroix; I Fliss
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

5.  Bifidobacterium Bacteremia: Clinical Characteristics and a Genomic Approach To Assess Pathogenicity.

Authors:  Eirin Esaiassen; Erik Hjerde; Jorunn Pauline Cavanagh; Gunnar Skov Simonsen; Claus Klingenberg
Journal:  J Clin Microbiol       Date:  2017-05-10       Impact factor: 5.948

6.  Antibiotic susceptibility of Lactobacillus and Bifidobacterium species from the human gastrointestinal tract.

Authors:  Susana Delgado; Ana Belén Flórez; Baltasar Mayo
Journal:  Curr Microbiol       Date:  2005-03-15       Impact factor: 2.188

7.  Susceptibility of bifidobacteria of animal origin to selected antimicrobial agents.

Authors:  Sigrid Mayrhofer; Christiane Mair; Wolfgang Kneifel; Konrad J Domig
Journal:  Chemother Res Pract       Date:  2011-04-05

8.  Long-term changes in human colonic Bifidobacterium populations induced by a 5-day oral amoxicillin-clavulanic acid treatment.

Authors:  Irène Mangin; Christophe Lévêque; Fabien Magne; Antonia Suau; Philippe Pochart
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

9.  Antibiotic susceptibility of Atopobium vaginae.

Authors:  Ellen De Backer; Rita Verhelst; Hans Verstraelen; Geert Claeys; Gerda Verschraegen; Marleen Temmerman; Mario Vaneechoutte
Journal:  BMC Infect Dis       Date:  2006-03-16       Impact factor: 3.090

10.  In silico assigned resistance genes confer Bifidobacterium with partial resistance to aminoglycosides but not to β-lactams.

Authors:  Fiona Fouhy; Mary O'Connell Motherway; Gerald F Fitzgerald; R Paul Ross; Catherine Stanton; Douwe van Sinderen; Paul D Cotter
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.